Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is on track to lose approximately $7.9 trillion worth of economic activity over the next ten years, regardless of the federal government’s astronomical stimulus spending in order to prop up the economy.

Although many restrictions across the US are being lifted and both consumers and businesses are slowly starting to recover, the financial effects of the coronavirus pandemic are most likely going to be felt well into fiscal 2030. The report estimates that real economic output will be reduced by at least 3% when compared to previous pre-pandemic estimates, meanwhile nominal GDP will see a reduction of 5.3% – which translates to approximately $15.7 trillion.

Furthermore, the CBO is anticipating GDP levels to drop by the most in US history in the second quarter of 2020, while the month of May will have an unemployment rate of approximately 20% – the highest since the Great Depression. As a result, Senator Chuck Schumer is calling on the Senate to approve another round of fiscal stimulus in order to mitigate the impending negative impacts on the economy.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

Information for this briefing was found via CNBC and the Congressional Budget Office. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Three Million Ounces of Gold, Barely Getting Started | Dylan Langille – White Gold

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Revive Therapeutics Sees FDA Recommend Phase 3 For COVID-19 Related Study Of Bucillamine

Revive Therapeutics (CSE: RVV) announced major news this morning related to its ongoing study of...

Thursday, April 23, 2020, 09:06:28 AM

Datametrex Sees Second Sale Of COVID-19 Test Kits To Canadian Mine Operator

Datametrex AI Limited (TSXV: DM) is in the business of recurring sales evidently. The company...

Wednesday, June 24, 2020, 09:00:32 AM

Food Shortages May Become Reality Amid Coronavirus Pandemic

The global coronavirus pandemic has wreaked havoc across economies, closing down businesses, putting millions out...

Friday, April 24, 2020, 07:50:33 AM

Coronavirus Cases Continue to Soar Across the US, Surge in Death Rates Follows Suit

As the coronavirus pandemic continues to spread around the world, there is one country in...

Saturday, August 1, 2020, 05:06:00 PM

US Coronavirus Cases Surpass 6 Million, Some Cities Waiting for Vaccine Before Lifting Restrictions

Many states across the US have been eagerly lifting restrictions and lockdown measures in a...

Tuesday, September 1, 2020, 11:10:56 AM